Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Maxalt Melt 10mg oral lyophilisates
0407041R0BBACAC
|
Maxalt | Rizatriptan | Central Nervous System | 10,057 |
|
Maxalt 10mg tablets
0407041R0BBABAB
|
Maxalt | Rizatriptan | Central Nervous System | 1,460 |
|
Maxalt 5mg tablets
0407041R0BBAAAA
|
Maxalt | Rizatriptan | Central Nervous System | 351 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.